Magnesium Bisglycinate for Health & Longevity - Quick Reference Sheet

Magnesium Bisglycinate for Health & Longevity

Created on 07/08/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A well-absorbed, gentle form of an essential mineral most adults lack. Best evidence: it reliably restores low magnesium and modestly lowers blood pressure in those running high or low. Reasonable support for blood sugar and migraine. Sleep, calm, and cramp claims are popular but weaker. Generally safe; loose stools are the limit, and reduced kidney function is the main concern. (Full Review)

Protocol

Standard Dose
200–400 mg/day
Elemental magnesium from bisglycinate, scaled to diet and starting status
Timing
30–60 min before bed
For sleep and calm; flexible and with meals for general repletion
Split Dosing
2–3 divided doses
Improves absorption and tolerability versus one large dose
Time to effect
Deficiency Correction
Weeks
Correcting true deficiency takes weeks of consistent intake
Blood Pressure & Metabolic
Several weeks
Blood-pressure and metabolic changes with consistent daily use
Sleep & Calm
Within days
Where present, may be noticed within days

Benefits

Contraindications
  • Advanced chronic kidney disease (eGFR below 30)
  • Severe heart block or marked bradycardia
  • Myasthenia gravis
Key Interactions
  • Reduces absorption of antibiotics (tetracyclines, fluoroquinolones), bisphosphonates, and levothyroxine
  • Additive with antihypertensive drugs and, at high doses, muscle relaxants
  • Magnesium-containing antacids and laxatives add to total intake
  • Long-term proton pump inhibitors lower magnesium levels
  • High-dose zinc or large single-dose calcium reduce absorption
  • Additive with blood-pressure or calming supplements (potassium, taurine, L-theanine, glycine)
  • Alcohol and loop or thiazide diuretics deplete magnesium

Risk & Side Effects

  • High: Gastrointestinal upset and loose stools
  • Medium: Hypermagnesemia in kidney impairment
  • Low: Interference with absorption of other medications; additive blood-pressure lowering and hypotension
  • Speculative: Unknown long-term effects of sustained high-dose supplementation

Monitoring

Marker Target Why
Serum magnesium 2.0–2.6 mg/dL Screens for deficiency or, in kidney disease, accumulation
RBC magnesium 4.2–6.8 mg/dL Reflects tissue magnesium status better than serum
Blood pressure <120/80 mmHg Tracks a key benefit in hypertensive or low-magnesium users
Fasting glucose / HbA1c Fasting <90 mg/dL; HbA1c <5.4% Tracks metabolic benefit in diabetes or insulin resistance
eGFR (kidney function) >90 mL/min/1.73 m² Confirms the kidneys can clear excess magnesium

Cadence: Recheck at 8–12 weeks after starting or a dose change, then every 6–12 months; closer follow-up with kidney disease, diabetes, or interacting medications.

Qualitative Assessment

  • Sleep quality and how quickly one falls asleep
  • Daytime energy and freedom from unexplained fatigue
  • Frequency of muscle twitches, eyelid flutter, or cramps
  • Subjective calm and stress resilience
  • Regularity and comfort of bowel movements (early cue the dose is too high)